Sending Tissue Samples to Space for MS, Parkinson’s Research
NSCF will send human brain organoids derived from patients with two different types of degenerative brain diseases—Parkinson’s and PPMS—to the orbiting laboratory.
NSCF will send human brain organoids derived from patients with two different types of degenerative brain diseases—Parkinson’s and PPMS—to the orbiting laboratory.
The gut microbiome is involved in multiple pathways in the pathogenesis of Parkinson’s disease, researchers suggest.
The FDA-cleared Parky App monitors Parkinson's symptoms such as tremors and dyskinesia in real time via the use of the Apple Watch.
By continuously monitoring a patient’s gait speed, the system can assess Parkinson’s severity between visits to the doctor’s office.
Read MoreAggregates of the protein alpha-synuclein spread in the brains of people with Parkinson’s disease through a cellular waste-ejection process.
Read MoreResearchers discover how a build-up of protein starts to happen within neurons in Parkinson’s disease, ultimately causing nerve cell death.
Read MorePMD Alliance and Neurocrine Biosciences announce results of a survey revealing the impact of OFF Time on people with Parkinson’s disease.
Read MoreA hormone secreted during exercise reduces levels of a protein linked to Parkinson’s disease and halts movement problems in mice.
Read MoreThe Parkinson’s Foundation Global Care Network seeks applications for medical centers providing outstanding clinical care and resources.
Read MoreUNF is recruiting participants for a free exercise therapy program to improve both physical and mental health for persons with Parkinson’s.
Read MoreTeam Synapse – 12 runners living with Parkinson’s Disease – will participate in the 208-mile Blue Ridge Relay on September 9-10.
Read MoreSeelos Therapeutics Inc received funding to advance preclinical research and development of its gene therapy delivered SLS-004 program.
Read MoreRegister now for this free webinar from Xtalks: Current and Emerging Biomarkers to Advance Clinical Research in Parkinson’s Disease.
Read MoreResearchers at RUSH University Medical Center hope new findings will mitigate and improve Parkinson’s symptoms and prevent new ones.
Read MoreThe Parkinson’s Foundation announces an investment of $5.7 million in 33 grants to accelerate cutting-edge Parkinson’s disease research.
Read MoreThe Michael J. Fox Foundation for Parkinson’s Research awards Koneksa a second research grant to evaluate progression using digital measures.
Read MoreThe gene mutation responsible for hemochromatosis may be a risk factor for developing movement disorders, such as Parkinson’s disease.
Read MoreResearch takes scientists closer to understanding α-synuclein (αSyn), which they find links inflammation and Parkinson’s disease.
Read More